Application of sustained delivery microsphere of cyclosporine A for preventing posterior capsular opacification in rabbits

International Journal of Ophthalmology

Volumn 6, Issue 1, 2013, Pages 1-7

  Pei, Cheng ^a   Xu, Yi ^b   Jiang, Jean Xin ^c   Cui, Li Jun ^a   Li, Li ^a   Qin, Li ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b Center for Disease Control and Prevention of Shaanxi Province   (China)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Posterior capsular opacification; Rabbit eyes; Sustained cyclosporine A delivery microsphere

Indexed keywords

EID: 84894529963     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2013.01.01     Document Type: Article

References (22)

1. Schaumberg DA, Dana MR, Christen WG, Glynn RJ A systematic overview of the incidence of posterior capsular opacification. Ophthalmology. 1998;105(7):1213-1221.
2. Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UF, Tsai JC, Castaneda VE, Hoggatt JP, Kostick AM. Posterior capsule opacification. Surv Ophthalmol. 1992;37(2):73-116.
3. You YS, Lim SJ, Chung HS, Lee YG, Kim CY, Hong YJ The effective concentration and exposure time of mitomycin-C for the inhibition of lens epithelial cell proliferation in rabbit eyes. Yonsei Med J. 2000;41(2):185-189.
4. Inan UU, Oztürk F, Kaynak S., Kurt E, Emiroǧlu L, Ozer E., Ilker SS, Güler C. Prevention of posterior capsule of a dexamethasone anterior segment drug delivery system in patients opacification by intraoperative single dose pharmacologic agents. J Cataract Refract Surg. 2001;27(7):1079-1087.
5. Cortina P, Gómez-Lechón MJ, Navea A, Menezo JL, Terencio MC, Diaz-Llopis M. Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture. Graefes Arch Clin Exp Ophthalmol. 1997;235(3):180-185.
6. Prashar Y, Khanna A, Sehajpal P., Sharma VK, Suthanthiran M. Stimulation of transforming growth factor-beta 1 transcription by cyclosporine. FEBS Lett. 1995;358(2):109-112.
7. Shin GT, Khanna A, Ding R., Sharma VK, Lagman M, Li B, Suthanthiran M. In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine. Transplantation. 1998;65(3):313-318.
8. BenZera D, Maftzir G. Ocular penetration of cyclosporin A. The rabbit eye. Invest Ophthalmol Vis Sci. 1990;31(7):1362-1366.
9. BenEzra D, Maftzir G, de Courten C, Timonen P. Ocular penetration of cyclosporin A. III: The human eye. Br J Ophthalmol. 1990;74(6):350-352.
10. Mosteller MW, Gebhardt BM, Hamilton AM, Kaufman HE Penetration of topical cyclosporine into the rabbit cornea, aqueous humor, and serum. Arch Ophthalmol. 1985;103(1):101-102.
11. Nussenblatt RB, Dinning WJ, Fujikawa LS, Chan CC, Palestine AG Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch Ophthalmol. 1985;103(10):1559-1562.
12. Larkin DF. Corneal allograft rejection. Br J Ophthalmol. 1994;78(8):649-652.
13. Milani JK, Pleyer U, Dukes A., Chou HJ, Lutz S, Rückert D, Schmidt KH, Mondino BJ Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye. Ophthalmology. 1993;100(6):890-896.
14. Oh C, Apel AJ, Saville BA, Cheng YL, Rootman DS Local efficacy of cyclosporine in corneal transplant therapy. Curr Eye Res. 1994;13(5):337-343.
15. Pearson PA, Jaffe GJ, Martin DF, Cordahi GJ, Grossniklaus H, Schmeisser ET, Ashton P. Evaluation of a delivery system providing long-term release of cyclosporine. Arch Ophthalmol. 1996;114(3):311-317.
16. Charteris DG, Hiscott P, Robey HL, Gregor ZJ, Lightman SL, Grierson I. Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. Ophthalmology. 1993;100(1):43-46.
17. Enyedi LB, Pearson PA, Ashton P, Jaffe GJ An intravitreal device providing sustained release of cyclosporine and dexamethasone. Curr Eye Res. 1996;15(5):549-557.
18. Chen YJ, Xu XY, Zhou JP Progresses in lactic acid/glycolic acid microspheres research. Zhongguo Yaoke Daxue Xuebao. 2007;38(2):186-189.
19. Salgueiro A, Egea MA, Espina M, Valls O., García ML. Stability and ocular tolerance of cyclophosphamide-loaded nanospheres. J Microencapsul. 2004;21(2):213-223.
20. Pignatello R, Bucolo C, Puglisi G. Ocular tolerability of eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery. J Pharm Sci. 2002;91(12):2636-2641.
21. Yan L, Sun JD, Bi DZ Progresses in preparation of polylactic acid/polylactic glycolic acid copolymer microspheres and its quality affecting factors. Foreign Medical Sciences (Section on Pharmacy) 2001;28(3):165-167.
22. Liu ZS, Xie LX, Shi WY, Li SW, Cai Q, Bei JZ, Wang SG Drug release and biocompatibility of cyclosporine A drug delivery system implanting into the anterior chamber. Zhonghua Yanke Zazhi. 2004;40(2):110-112.